Sugar in Western diets increases risk for breast cancer tumors and metastasis
The high amounts of dietary sugar in the typical Western diet may increase the risk of breast cancer and metastasis to the lungs, according to a study at The University of Texas MD Anderson Cancer Center.
The findings, published in the Jan. 1 online issue of Cancer Research,demonstrated dietary sugar’s effect on an enzymatic signaling pathway known as 12-LOX (12-lipoxygenase).
“We found that sucrose intake in...
Immune suppressor cells identified for advanced prostate cancer
MD Anderson study reveals MDSCs as likely target for therapy development
Immune suppressor cells called MDSCs (myeloid-derived suppressor...
Pancreas cancer liquid biopsy flows from blood-borne packets of tumor genes
MD Anderson scientists do next-generation analysis of complete tumor genomes from exosomes
MD Anderson News Release 12/17/2015
‘Father of Tamoxifen’ receives Sir James Black Award
V. Craig Jordan, Ph.D., a breast cancer research pioneer known for his development of the therapeutic drug tamoxifen, has been named a recipient of the Sir James Black Award from the British Pharmacological Society.
Jordan, a professor in the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, will be presented the award today at the award ceremony to take place in London. The award recognizes...
Mastectomy plus reconstruction has highest rate of complication, complication-related costs of guideline-concordant therapies for early breast cancer
Treatment modality is also the most expensive in younger patients, MD Anderson study finds
MD Anderson News Release 12/10/2015
Lymphoma/Myeloma symposium for patients and caregivers set for Jan. 9
MD Anderson News Release 12/10/2015
Patients with lymphoma or myeloma and their caregivers will have access to leading experts...
Delaying chemotherapy in breast cancer patients reduces overall survival, especially for those with triple-negative breast cancer
MD Anderson study identifies socio-demographic factors contributing to delayed treatment
MD Anderson News Release 12/10/2015
...
Multiple myeloma patient study shows promise for natural killer cells
Phase I study included combination with high-dose chemotherapy and stem cell transplantation
MD Anderson News Release 12/07/2015<...
Loss of enzyme promotes tumor progression in endometrial cancer
MD Anderson News Release 12/07/2015
Scientists have shown for the first time why loss of the enzyme CD73 in human cancer...
Study shows ibrutinib superior to traditional chemotherapy in untreated chronic leukemia patients
Results cite 97.8 percent overall survival rates after two years vs. 85.3 percent for chlorambucil
MD Anderson News Release 12/06...